Nitya Nair, Ph.D. - Publications

Affiliations: 
2009 Johns Hopkins University, Baltimore, MD 
Area:
Immunology, Microbiology Biology, Virology Biology

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Nair N, Chen SY, Lemmens E, Chang S, Le DT, Jaffee EM, Murphy A, Whiting C, Müller T, Brockstedt DG. SINGLE-CELL IMMUNE COMPETENCY SIGNATURES ASSOCIATE WITH SURVIVAL IN PHASE 2 GVAX AND CRS-207 RANDOMIZED STUDIES IN METASTATIC PANCREATIC CANCER PATIENTS. Cancer Immunology Research. PMID 32132105 DOI: 10.1158/2326-6066.Cir-19-0650  0.301
2019 Hassan R, Alley E, Kindler H, Antonia SJ, Jahan TM, Honarmand S, Nair N, Whiting C, Enstrom A, Lemmens E, Tsujikawa T, Kumar S, Choe G, Thomas A, McDougall K, et al. Live-Attenuated, Listeria monocytogenes Expressing Mesothelin (CRS-207) with Chemotherapy for Treatment of Malignant Pleural Mesothelioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31263030 DOI: 10.1158/1078-0432.Ccr-19-0070  0.353
2019 Le DT, Picozzi VJ, Ko AH, Wainberg ZA, Kindler H, Wang-Gillam A, Oberstein PE, Morse MA, Zeh H, Weekes CD, Reid T, Borazanci E, Crocenzi T, LoConte NK, Musher B, ... ... Nair N, et al. A randomized Phase 2b study of GVAX pancreas and CRS-207 compared to chemotherapy in previously-treated metastatic pancreatic adenocarcinoma patients (ECLIPSE Study). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31126960 DOI: 10.1158/1078-0432.Ccr-18-2992  0.301
2019 Alley EW, Tanvetyanon T, Jahan TM, Gandhi L, Peikert T, Stevenson J, Schlienger K, Liu W, Nair N, Honarmand S, Kindler HL. A phase II single-arm study of CRS-207 with pembrolizumab (pembro) in previously treated malignant pleural mesothelioma (MPM). Journal of Clinical Oncology. 37: 29-29. DOI: 10.1200/Jco.2019.37.8_Suppl.29  0.324
2019 Bensinger W, Raptis A, Berenson JR, Spira AI, Nooka AK, Chaudhry M, van Zandvoort P, Nair N, Lo J, Elassaiss-Schaap J, Walling J, Hari P. Safety and tolerability of BION-1301 in adults with relapsed or refractory multiple myeloma. Journal of Clinical Oncology. 37: 8012-8012. DOI: 10.1200/Jco.2019.37.15_Suppl.8012  0.339
2017 Nair N, Feng N, Blum LK, Sanyal M, Ding S, Jiang B, Sen A, Morton JM, He XS, Robinson WH, Greenberg HB. VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans. Science Translational Medicine. 9. PMID 28637924 DOI: 10.1126/Scitranslmed.Aam5434  0.443
2017 Le DT, Ko AH, Wainberg ZA, Picozzi VJ, Kindler HL, Wang-Gillam A, Oberstein PE, Morse M, Zeh H, Weekes CD, Reid TR, Murphy A, McDougall K, Whiting CC, Nair N, et al. Results from a phase 2b, randomized, multicenter study of GVAX pancreas and CRS-207 compared to chemotherapy in adults with previously-treated metastatic pancreatic adenocarcinoma (ECLIPSE Study). Journal of Clinical Oncology. 35: 345-345. DOI: 10.1200/Jco.2017.35.4_Suppl.345  0.363
2016 Le DT, Whiting CC, Lutz ER, Nair N, Engstrom A, Lemmens E, Tagliaferri MC, Murphy AL, Brockstedt DG, Jaffee EM. Clinical and immune characteristics of rapid dropout and long-term survival in a phase II safety and efficacy study of combination CRS-207/GVAX immunotherapy in pancreatic cancer. Journal of Clinical Oncology. 34: 459-459. DOI: 10.1200/Jco.2016.34.4_Suppl.459  0.355
2016 Deng W, Tsujikawa T, Nair N, Hudson T, Liu W, Rae CS, Lemmens EE, Desbien AW, Hanson W, Lauer P, Coussens LM, Brockstedt DG, Dubensky TW, Leong ML. Abstract A013: Favorable changes in tumor microenvironment following intravenous dosing with live attenuatedListeria monocytogenes-based immunotherapy Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-A013  0.34
2015 Nair N, Newell EW, Vollmers C, Quake SR, Morton JM, Davis MM, He XS, Greenberg HB. High-dimensional immune profiling of total and rotavirus VP6-specific intestinal and circulating B cells by mass cytometry. Mucosal Immunology. PMID 25899688 DOI: 10.1038/Mi.2015.36  0.307
2015 Whiting C, Lutz E, Nair N, Chang S, Lemmens E, Chen SY, Solt S, Ferber S, Maecker H, Murphy A, Brockstedt DG, Jaffee EM, Le DT. Phase II, randomized study of GVAX pancreas and CRS-207 immunotherapy in patients with metastatic pancreatic cancer: Clinical update on long term survival and biomarker correlates to overall survival. Journal of Clinical Oncology. 33: 261-261. DOI: 10.1200/Jco.2015.33.3_Suppl.261  0.414
2015 Hassan R, Antonia SJ, Alley EW, Kindler HL, Jahan T, Grous JJ, Honarmand S, McDougall K, Whiting CC, Nair N, Lemmens E, Murphy AL, Thomas A, Brockstedt DG. Mesothelin-targeted immunotherapy CRS-207 in combination with standard of care chemotherapy as treatment for malignant pleural mesothelioma (MPM). Journal of Clinical Oncology. 33: 7565-7565. DOI: 10.1200/Jco.2015.33.15_Suppl.7565  0.418
2015 Nair N, Lemmens E, Enstrom A, Chen S, Chang S, Le D, Jaffee EM, Maecker H, Murphy AL, Brockstedt DG, Whiting C. Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P102  0.347
2013 Nair N, Buti L, Faenzi E, Buricchi F, Nuti S, Sammicheli C, Tavarini S, Popp MW, Ploegh H, Berti F, Pizza M, Castellino F, Finco O, Rappuoli R, Del Giudice G, et al. Optimized fluorescent labeling to identify memory B cells specific for Neisseria meningitidis serogroup B vaccine antigens ex vivo. Immunity, Inflammation and Disease. 1: 3-13. PMID 25400913 DOI: 10.1002/Iid3.3  0.373
2013 Newell EW, Sigal N, Nair N, Kidd BA, Greenberg HB, Davis MM. Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization. Nature Biotechnology. 31: 623-9. PMID 23748502 DOI: 10.1038/Nbt.2593  0.349
2013 Rothenberg ME, Sen A, Mukherjee G, Feng N, Kalisky T, Nair N, Johnstone IM, Clarke MF, Greenberg HB. 549 A Novel Approach to Understanding Viral Pathogenesis: Defining in-Vivo Rotavirus Infection of Intestinal Enterocytes At the Single Cell Level by Comparing Infected Cells, Bystanders, and Uninfected Cells Gastroenterology. 144: S-100. DOI: 10.1016/S0016-5085(13)60369-8  0.305
2012 Sen A, Rothenberg ME, Mukherjee G, Feng N, Kalisky T, Nair N, Johnstone IM, Clarke MF, Greenberg HB. Innate immune response to homologous rotavirus infection in the small intestinal villous epithelium at single-cell resolution. Proceedings of the National Academy of Sciences of the United States of America. 109: 20667-72. PMID 23188796 DOI: 10.1073/Pnas.1212188109  0.309
2009 Nair N, Moss WJ, Scott S, Mugala N, Ndhlovu ZM, Lilo K, Ryon JJ, Monze M, Quinn TC, Cousens S, Cutts F, Griffin DE. HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection. The Journal of Infectious Diseases. 200: 1031-8. PMID 19702505 DOI: 10.1086/605648  0.602
2008 Pan CH, Jimenez GS, Nair N, Wei Q, Adams RJ, Polack FP, Rolland A, Vilalta A, Griffin DE. Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virus. Clinical and Vaccine Immunology : Cvi. 15: 1214-21. PMID 18524884 DOI: 10.1128/Cvi.00120-08  0.555
2008 Pan CH, Nair N, Adams RJ, Zink MC, Lee EY, Polack FP, Singh M, O'Hagan DT, Griffin DE. Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques. Clinical and Vaccine Immunology : Cvi. 15: 697-706. PMID 18287579 DOI: 10.1128/Cvi.00045-08  0.569
2007 Nair N, Gans H, Lew-Yasukawa L, Long-Wagar AC, Arvin A, Griffin DE. Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life. The Journal of Infectious Diseases. 196: 1339-45. PMID 17922398 DOI: 10.1086/522519  0.528
2005 Pan CH, Valsamakis A, Colella T, Nair N, Adams RJ, Polack FP, Greer CE, Perri S, Polo JM, Griffin DE. Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles. Proceedings of the National Academy of Sciences of the United States of America. 102: 11581-8. PMID 16037211 DOI: 10.1073/Pnas.0504592102  0.56
Show low-probability matches.